These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10700782)

  • 1. Effects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived from Patients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants.
    Miyoshi H; Otsuki S; Mukaida K; Kido K; Sumii A; Ikeda T; Noda Y; Yasuda T; Narasaki S; Kato T; Kamiya S; Horikawa YT; Tsutsumi YM
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.
    Giulivi C; Ross-Inta C; Omanska-Klusek A; Napoli E; Sakaguchi D; Barrientos G; Allen PD; Pessah IN
    J Biol Chem; 2011 Jan; 286(1):99-113. PubMed ID: 20978128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Remimazolam and Propofol on Ca
    Watanabe T; Miyoshi H; Noda Y; Narasaki S; Morio A; Toyota Y; Kimura H; Mukaida K; Yasuda T; Tsutsumi YM
    Biomed Res Int; 2021; 2021():8845129. PubMed ID: 33490280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermetabolism in B-lymphocytes from malignant hyperthermia susceptible individuals.
    Hoppe K; Hack G; Lehmann-Horn F; Jurkat-Rott K; Wearing S; Zullo A; Carsana A; Klingler W
    Sci Rep; 2016 Sep; 6():33372. PubMed ID: 27646467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal loop of the ryanodine receptor: a pore-forming segment?
    Balshaw D; Gao L; Meissner G
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3345-7. PubMed ID: 10097041
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant.
    Herdewyn S; De Bleecker J; Janssens L; Symoens S; Milazzo M; De Puydt J
    Neuromuscul Disord; 2024 Feb; 35():39. PubMed ID: 38237271
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant.
    Voermans NC; Yang C; Schouten M; Girard T; Stowell K; Riazi S; Kamsteeg EJ; Snoeck M
    Neuromuscul Disord; 2024 Feb; 35():40-41. PubMed ID: 38007345
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiological and clinical features of malignant hyperthermia: A scoping review.
    Cong Z; Wan T; Wang J; Feng L; Cao C; Li Z; Wang X; Han Y; Zhou Y; Gao Y; Zhang J; Qu Y; Guo X
    Clin Genet; 2024 Mar; 105(3):233-242. PubMed ID: 38148504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging Effects of
    Nicoll Baines K; Ferreira C; Hopkins PM; Shaw MA; Hope IA
    G3 (Bethesda); 2017 May; 7(5):1451-1461. PubMed ID: 28325813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
    Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
    Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zullo A; Perrotta G; D'Angelo R; Ruggiero L; Gravino E; Del Vecchio L; Santoro L; Salvatore F; Carsana A
    Biomed Res Int; 2019; 2019():7638946. PubMed ID: 31165076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.
    Carsana A
    ScientificWorldJournal; 2013; 2013():531465. PubMed ID: 23476141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes.
    Brinkmeier H; Krämer J; Krämer R; Iaizzo PA; Baur C; Lehmann-Horn F; Rüdel R
    Br J Anaesth; 1999 Dec; 83(6):855-61. PubMed ID: 10700782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.
    Girard T; Treves S; Censier K; Mueller CR; Zorzato F; Urwyler A
    Br J Anaesth; 2002 Oct; 89(4):571-9. PubMed ID: 12393358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K; Urwyler A; Zorzato F; Treves S
    J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.